Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs ...
The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.
Mr Bourla does not say in the interview that COVID jabs are dangerous. The interview begins at the 35 seconds mark of the ...
U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that ...
Pfizer said it will 'support capacity-building initiatives, such as training healthcare professionals and advancing clinical ...
The general mood among these heavyweight investors is divided, with 33% leaning bullish and 50% bearish. Among these notable ...
Oklahoma City Indian Clinic announced it has received a $250,000 charitable contribution from Pfizer to support programs ...
Pfizer CEO Albert Bourla joins CNBC's 'Special Report' as President-elect Donald Trump is inaugurated as the 47th U.S.